Medical Bionic Implants Market Size, Share, Analysis Report

Medical Bionic Implants Market By Product Analysis (Artificial Organs, Bionic Implants); By Method of fixation Analysis (Implantable, Externally Worn); By Technology Analysis (Electronic, Mechanical) and By Regional Analysis – Global Forecast by

The Global Medical Bionic Implants Market is expected to be around US$ 32.70 billion by 2028 and will grow at a CAGR of more than 7% in the given forecast period.

Purchase User License

MARKET SNAPSHOT

Major Players

Study period:

2023-2028

Base Year:

2022

CAGR:

7

Fastest Growing Market:

APAC

Largest Market:

North America

REPORT DESCRIPTION

In medicine, a bionic refers to an artificial robot body element. Bionic implanting is a technique of changing or enhancing the capability of an organ by way of replacing it with robot element. With the advent of improved generation, it has turn out to be feasible to implement the use of robotics in human organs. The Global Medical Bionic Implants Market is advancing and has witnessed growth in the last two decades and is predicted to grow in addition inside the destiny. Artificial organs are manmade implants which might be included in human frame to imitate the characteristic of original organ. Further, bionics is a collaboration of electronics and biology. Medical bionics are robot alternative of other components of body. Those bionics mimics the function of natural biological structures.
 
How Big is the Global Medical Bionic Implants Market?
 
The Global Medical Bionic Implants Market is expected to be around US$ 32.70 billion by 2028 and will grow at a CAGR of more than 7% in the given forecast period.
 
The major driving factors of Global Medical Bionic Implants Market are as follows:
 
•    Growing population 
•    Increasing road accidents
 
The restraining factors of Global Medical Bionic Implants Market are as follows:
 
•    High rate of treatment
•    Limited surgical expertise
•    Expensive devices
 
The Global Medical Bionic Implants Market is segmented on the lines of its product, method of fixation, technology and regional. Product is further segmented into artificial organs and bionic implants.  Artificial organs is classified into artificial heart, artificial kidney, total artificial heart, artificial liver, insulin pumps, haemodialysis machines, artificial lungs, artificial pancreas and oxygenators. A bionic implant covers ear bionics, orthopaedic bionics, vision bionics, neural /brain bionics, heart bionics and biological tissue valves. Method of fixation is segmented into implantable and externally worn. Technology segmentation is classified into electronic and mechanical technology. The Global Medical Bionic Implants Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
 
This report provides:
1) An overview of the global market for medical bionic implants and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Medical Bionic Implants Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE: 
 
The scope of the report includes a detailed study of global and regional markets Global Medical Bionic Implants Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include LifeNet Health U.S., Terumo Corporation, Össur U.S., EKSO Bionics, Nano Retina Inc., Israel, Second Sight Medical Products, Edwards Life Sciences Corporation, Medtronic Inc. Tibion Corporation, Touch Bionics Limited, Otto Bock Healthcare, Orthofix International U.S.A., and the Boston Scientific Corporation among others. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. 

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players. 

The Global Medical Bionic Implants Market has been segmented as below:

By Product Analysis

•    Artificial Organs
    o    Artificial Heart
    o    Artificial Kidney
    o    Total Artificial Heart (TAH)
    o    Artificial Liver
    o    Insulin Pumps
    o    Haemodialysis Machines
    o    Artificial Lungs
    o    Artificial Pancreas
    o    Oxygenators

 
•    Bionic Implants
    o    Ear Bionics
    o    Orthopaedic Bionics
    o    Vision Bionics
    o    Neural /Brain Bionics
    o    Heart Bionics
    o    Biological Tissue Valves
By Method of fixation Analysis

•    Implantable
•    Externally Worn

By Technology Analysis

•    Electronic
•    Mechanical

By Regional Analysis

•    North America
•    Europe
•    Asia-Pacific
•    Rest of the World

Reasons to Buy this Report: 
1) Obtain the most up to date information available on all Global Medical Bionic Implants Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Medical Bionic Implants Market data.
4) Assess your competitor’s refining portfolio and its evolution.

Customization:
We can offer you custom research reports as per client’s special requirements.

Below are our new reports:

Dental Imaging (X-Ray) Market

Dental Implant Market

Dental Implants & Prosthetics Market

Dental Implants and Prosthetics Market

Dental Implants Market

1 INTRODUCTION    

    1.1    Key Take Aways    
    1.2    Report Description    
    1.3    Markets Covered    
    1.4    Stakeholders    
    1.5    Research Methodology    
        1.5.1    Market Size    
        1.5.2    Market Share    
        1.5.3    Key Data Points From Secondary Sources    
        1.5.4    Key Data Points From Primary Sources
 

2 EXECUTIVE SUMMARY

 

3 MARKET OVERVIEW
   3.1 INTRODUCTION
   3.2 EVOLUTION
   3.3 MARKET SEGMENTATION
   3.4 BIONICS & PROSTHESES: SIMILARITIES & DIFFERENCES
   3.5 MARKET DYNAMICS
         3.5.1 DRIVERS
                  3.5.1.1 TECHNOLOGICAL ADVANCEMENTS
                  3.5.1.2 INCREASING ORGAN FAILURE OWING TO AGING & AGE-RELATED DISORDERS
                  3.5.1.3 INCREASING ACCIDENTS & INJURIES LEADING TO AMPUTATIONS.
                  3.5.1.4 RISE IN NUMBER OF PEOPLE AWAITING ORGAN TRANSPLANTS
         3.5.2 RESTRAINTS
                  3.5.2.1 HIGH COST OF DEVICES AND UNCERTAIN REIMBURSEMENT
                              SCENARIOS IN DIFFERENT REGIONS
                  3.5.2.2 LIMITED SURGICAL EXPERTISE
                  3.5.2.3 HIGH COST OF DEVELOPMENT
         3.5.3 OPPORTUNITIES
                  3.5.3.1 ADVANTAGEOUS IN COMPARISON PROSTHETICS
                  3.5.3.2 IMPROVING INCOME LEVELS & RISING AWARENESS COULD
                              PUSH DEMAND IN EMERGING ECONOMIES
   3.6 MARKET SHARE ANALYSIS
         3.6.1 EAR BIONICS MARKET
         3.6.2 ORTHOPEDIC BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET
         3.6.3 HEART BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET
         3.6.4 BRAIN/NEURAL BIONICS MARKET
   3.7 EMERGING TECHNOLOGIES
         3.7.1 BIONICS IMPLANT/ARTIFICIAL ORGANS IN THE PIPELINE
                  3.7.1.1 ARTIFICIAL PANCREAS
                  3.7.1.2 BIO-LUNG
                  3.7.1.3 WEARABLE ARTIFICIAL KIDNEY

 

4 GLOBAL MEDICAL BIONIC IMPLANT/ARTIFICIAL ORGANS MARKET, BY PRODUCTS
   4.1 INTRODUCTION
   4.2 VISION BIONICS
         4.2.1 BIONIC EYE
   4.3 EAR BIONICS
         4.3.1 COCHLEAR IMPLANT
         4.3.2 BONE ANCHORED HEARING AID (BAHA)
   4.4 ORTHOPEDIC BIONICS
         4.4.1 BIONIC LIMB
                  4.4.1.1 BIONIC HAND
                  4.4.1.2 BIONIC LEG
                              4.4.1.2.1 BIONIC KNEE
                              4.4.1.2.2 BIONIC FEET
         4.4.2 BIONIC FINGER
         4.4.3 EXOSKELETON
         4.4.4 ELECTRICAL BONE GROWTH STIMULATORS
                  4.4.4.1 INVASIVE BONE GROWTH STIMULATORS
                  4.4.4.2 NON-INVASIVE BONE GROWTH STIMULATORS
   4.5 HEART BIONICS
         4.5.1 PACEMAKER
                  4.5.1.1 IMPLANTABLE CARDIAC PACEMAKER
                  4.5.1.2 EXTERNAL PACEMAKER
         4.5.2 TOTAL ARTIFICIAL HEART
         4.5.3 VENTRICULAR ASSIST DEVICE
         4.5.4 ARTIFICIAL HEART VALVE
                  4.5.4.1 MECHANICAL HEART VALVE
                  4.5.4.2 TISSUE HEART VALVE
   4.6 NEURAL/BRAIN BIONICS
                  4.6.1.1 DEEP BRAIN STIMULATOR
                  4.6.1.2 VAGUS NERVE STIMULATOR
                  4.6.1.3 SPINAL CORD STIMULATOR

 

5 GLOBAL MEDICAL BIONIC IMPLANT/ARTIFICIAL ORGANS MARKET, BY TECHNOLOGY
   5.1 INTRODUCTION
   5.2 ELECTRONIC BIONICS
   5.3 MECHANICAL

 

6 GLOBAL MEDICAL BIONIC IMPLANT/ARTIFICIAL ORGANS MARKET, BY TYPE OF FIXATION
   6.1 INTRODUCTION
   6.2 EXTERNALLY WORN
   6.3 IMPLANTABLE

 

7 GEOGRAPHIC ANALYSIS
   7.1 INTRODUCTION
   7.2 NORTH AMERICA
   7.3 EUROPE
   7.4 ASIA- PACIFIC
   7.5 ROW

 

8 COMPETITIVE LANDSCAPE
   8.1 INTRODUCTION
   8.2 MERGERS & ACQUISITIONS
   8.3 AGREEMENTS, PARTNERSHIPS & COLLABORATIONS
   8.4 NEW PRODUCT LAUNCH
   8.5 APPROVALS
   8.6 EXPANSION
   8.7 OTHER DEVELOPMENTS

 

9 COMPANY PROFILES
   9.1 ABIOMED, INC.
   9.2 BERLIN HEART GMBH
   9.3 BIOMET, INC.
   9.4 BOSTON SCIENTIFIC CORPORATION
   9.5 COCHLEAR, LTD.
   9.6 EDWARDS LIFESCIENCES CORPORATION
   9.7 EKSO BIONICS
   9.8 HEARTWARE INTERNATIONAL, INC.
   9.9 IWALK, INC.
   9.10 JARVIK HEART, INC.
   9.11 LIFENET HEALTH
   9.12 MED-EL ELEKTROMEDIZINISCHE GERÄTE G.M.B.H.
   9.13 MEDTRONIC, INC.
   9.14 NANO RETINA, INC.
   9.15 ORTHOFIX INTERNATIONAL N.V.
   9.16 OSSUR
   9.17 OTTO BOCK HEALTHCARE GMBH.
   9.18 SECOND SIGHT MEDICAL PRODUCTS, INC.
   9.19 SONOVA HOLDING AG
   9.20 ST. JUDE MEDICAL, INC.
   9.21 SORIN S.P.A.
   9.22 TERUMO CORPORATION
   9.23 THORATEC CORPORATION
   9.24 TIBION CORPORATION
   9.25 TOUCH BIONICS, LTD.

The Global Medical Bionic Implants Market has been segmented as below:
 
By Product Analysis

•    Artificial Organs
    o    Artificial Heart
    o    Artificial Kidney
    o    Total Artificial Heart (TAH)
    o    Artificial Liver
    o    Insulin Pumps
    o    Haemodialysis Machines
    o    Artificial Lungs
    o    Artificial Pancreas
    o    Oxygenators

 
•    Bionic Implants
    o    Ear Bionics
    o    Orthopaedic Bionics
    o    Vision Bionics
    o    Neural /Brain Bionics
    o    Heart Bionics
    o    Biological Tissue Valves

By Method of fixation Analysis

•    Implantable
•    Externally Worn
 
By Technology Analysis

•    Electronic
•    Mechanical
 
By Regional Analysis

•    North America
•    Europe
•    Asia-Pacific
•    Rest of the World

Got a question? We've got answers. If you have some other questions, see our support center.

The market is expected to grow at a CAGR of 7% during the study period (2023-2028)
The Global Medical Bionic Implants Market is expected to be around US$ 32.70 billion by 2028.
The segment included in Medical Bionic Implants Market is Product, Method of fixation Analysis, Technology Analysis and region.
Some key players operating in the Medical Bionic Implants Market include LifeNet Health U.S., Terumo Corporation, Össur U.S., EKSO Bionics, Nano Retina Inc., Israel, Second Sight Medical Products, Edwards Life Sciences Corporation, Medtronic Inc
We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook

Related Reports